¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"gradient induced phase shift effect"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • photoconductive effect
    ±¤ÀüµµÈ¿°ú
  • photoelectric effect
    ±¤ÀüÈ¿°ú
  • photovoltaic effect
    ±¤±âÀü·ÂÈ¿°ú
  • piezoelectric effect
    ¾ÐÀüÈ¿°ú
  • placebo effect
    ¼ÓÀÓ¾àÈ¿°ú, Çö󼼺¸È¿°ú
  • plateau effect
    °í¿øÈ¿°ú
  • polar effect
    ±Ø¼ºÈ¿°ú
  • polarizing effect
    ºÐ±ØÈ¿°ú
  • pooling effect
    Àú·ùÈ¿°ú
  • priming effect
    ½Ãµ¿È¿°ú
  • prolonged effect
    Áö¼ÓÈ¿°ú
  • partial volume effect
    ºÎºÐ¿ëÀûÈ¿°ú
  • palliative effect
    ¿ÏÈ­È¿°ú, °æ°¨È¿°ú
  • rush effect
    ¼âµµÈ¿°ú
  • radiation effect
    ¹æ»ç¼±È¿°ú
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • detergent effect
    Á¤È­ÀÛ¿ë
  • deterministic effect
    È®Á¤Àû¿µÇâ
  • diabetogenic effect
    ´ç´¢À¯¹ßÈ¿°ú
  • dose rate effect
    ¼±·®À²È¿°ú
  • effect
    È¿°ú, ÀÛ¿ë
  • electrophonic effect
    Àü±âû°¢È¿°ú
  • entry slice effect
    ÁøÀÔÀýÆíÈ¿°ú
  • fast scan effect
    °í¼Ó½ºÄµÈ¿°ú
  • halo effect
    ´Þ¹«¸®È¿°ú
  • healthy worker effect
    °Ç°­±Ù·ÎÀÚÈ¿°ú
  • in-flow effect
    À¯ÀÔÈ¿°ú
  • indifferent effect
    ¹«°ü½ÉÀÛ¿ë
  • inhibitory effect
    ¾ïÁ¦È¿°ú
  • inotropic effect
    ¼öÃàÃËÁøÈ¿°ú
  • isotopic effect
    µ¿À§¿ø¼ÒÈ¿°ú
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • g2 phase
    ÇÕ¼ºÈıâ G2±â
  • gastric phase
    À§»ó(êÖßÓ) À§»êºÐºñ(êÖߤÝÂÝô)ÀÇ .
  • go phase
    Á¤Áö±â Go±â
  • grinding phase
    ºÐ¼â»ó.
  • implantational phase
    Âø»ó±â
  • in-phase image
    À§»ó³» ¿µ»ó
  • inactive phase
    ºñȰµ¿±â
  • inadequate luteal phase
    Ȳü±âºÎÀü(üÜô÷ÐïÝÕîï).
  • inadequate luteal phase
    Ȳü±âºÎÀü(üÜô÷ÐïÝÕîï).
  • inspiratory phase
    Èí±â»ó(ýåѨßÓ).
  • inspiratory phase time
    Èí±â»ó½Ã°£.
  • phallic stage (phase)
    ³²±Ù±â(ÑûÐÆÑ¢).
  • phase
    »ó, ±â
  • phase
    ˤȗ
  • phase 1 study
    ÀÓ»óÁ¦1»ó½ÃÇè.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • lens-induced glaucoma
    ¼öÁ¤Ã¼³ì³»Àå
  • lens-induced uveitis
    ¼öÁ¤Ã¼Æ÷µµ¸·¿°
  • magnetic field gradient
    ÀÚÀå °æ»ç
  • magnetic field gradient vector
    ÀÚÀå °æ»ç º¤ÅÍ
  • magnetic susceptibility gradient
    ÀÚ±âÈ­À² °æ»ç
  • magnetization prepared rapid acquisition gradient ec
    ÀÚÈ­ Áغñ °í¼Ó °æ»ç¿¡ÄÚ È¹µæ
  • maximum gradient strength
    ÃÖ´ë °æ»ç °­µµ
  • metabolic gradient
    ´ë»ç°æ»ç(¡­ÌËÞØ).
  • minimal current gradient
    ÃÖ¼ÒÀü·ù°æ»ç(¡­ï³êüÌËÞØ).
  • minimal current gradient
    ÃÖ¼ÒÀü·ù±¸¹è(¡­ï³êüÎþÛÕ).
  • motion compensation gradient
    ¿îµ¿ º¸»ó °æ»ç
  • myelitis, radiation-induced
    ¹æ»ç¼± À¯¹ß ô¼ö¿°
  • myelopathy, radiation-induced
    ¹æ»ç¼± À¯¹ß ô¼öº´Áõ
  • neuroleptic-induced disorders
  • noise induced hearing loss
    ¼ÒÀ½¼º³­Ã»
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á